Source: BioPortfolio

Igenica: Igenica Biotherapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 25102017 Prices from USD $250

SummaryIgenica Biotherapeutics Inc Igenica is a provider of antibody drug conjugate services. The company's product candidates includes IGN523 a humanized monoclonal antibody used to multiple hematologic and solid tumors. It offers IGN786 which is used nov...

Read full article »
Igenica's Competitors | Igenica's News | Igenica's Financials
Stay up-to-date with the latest news on Igenica
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Robert Schreiber's photo - Co-Founder of Igenica

Co-Founder

Robert Schreiber

CEO Approval Rating

78/100

Read more
Stay up-to-date with the latest news on Igenica